• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用五药方案长期治疗HIV-1感染期间病毒HLA-DR-CD4 T细胞储存库的持续性

Persistence of viral HLA-DR- CD4 T-cell reservoir during prolonged treatment of HIV-1 infection with a five-drug regimen.

作者信息

van Rij Ronald P, van Praag Rieneke M E, Prins Jan M, Rientsma Ronald, Jurriaans Suzanne, Lange Joep M A, Schuitemaker Hanneke

机构信息

Department of Clinical Viro Immunology, CLB/Sanquin and Landsteiner Laboratory of the Academic Medical Center, Amsterdam, The Netherlands.

出版信息

Antivir Ther. 2002 Mar;7(1):37-41.

PMID:12008786
Abstract

During sustained suppression of plasma viraemia using a standard triple-drug regimen, replication-competent HIV-1 can still be recovered from resting memory CD4 T cells. In an attempt to accelerate the clearance of this pool of infected CD4 T cells, eight antiretroviral therapy-naive HIV-1-infected patients were treated with a five-drug regimen. While plasma HIV-1 RNA levels generally remained below the level of detection (< 5 copies/ml), replication competent HIV-1 was isolated from HLA-DR- CD4 T cells from all patients on multiple occasions throughout treatment. Decay slopes of infected CD4 T cells ranged from -0.061/week (half-life=2.6 months) to +0.003/week (half-life = infinite). Virus was still detectable at the last time point analysed (80-173 weeks) in all patients. Although more intensive treatment results in improved suppression of plasma viraemia compared with standard drug regimens, it does not result in clearance of the viral reservoir in this timeframe. Strategies other than treatment with a combination of five of the currently available drugs need to be pursued in order to achieve eradication of HIV-1 from this cellular reservoir.

摘要

在使用标准三联药物疗法持续抑制血浆病毒血症期间,仍可从静息记忆CD4 T细胞中分离出具有复制能力的HIV-1。为了加速清除这群被感染的CD4 T细胞,对8例未接受过抗逆转录病毒治疗的HIV-1感染者采用五联药物疗法进行治疗。虽然血浆HIV-1 RNA水平通常保持在检测下限以下(<5拷贝/毫升),但在整个治疗过程中,多次从所有患者的HLA-DR-CD4 T细胞中分离出具有复制能力的HIV-1。被感染CD4 T细胞的衰减斜率范围为-0.061/周(半衰期=2.6个月)至+0.003/周(半衰期=无限)。在最后一个分析时间点(80-173周),所有患者体内仍可检测到病毒。尽管与标准药物疗法相比,更强化的治疗能更好地抑制血浆病毒血症,但在这个时间段内并不能清除病毒储存库。为了从这个细胞储存库中根除HIV-1,需要探索目前可用的五种药物联合治疗以外的策略。

相似文献

1
Persistence of viral HLA-DR- CD4 T-cell reservoir during prolonged treatment of HIV-1 infection with a five-drug regimen.采用五药方案长期治疗HIV-1感染期间病毒HLA-DR-CD4 T细胞储存库的持续性
Antivir Ther. 2002 Mar;7(1):37-41.
2
Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.在原发性HIV-1感染期间开始接受三联五类药物抗逆转录病毒疗法的患者中,受感染的静止CD4 HLA-DR- T淋巴细胞池的动态变化。
Antivir Ther. 2003 Apr;8(2):137-42.
3
Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy.CD4+ T细胞的潜伏感染为HIV-1的终身持续存在提供了一种机制,即使是接受有效联合治疗的患者也是如此。
Nat Med. 1999 May;5(5):512-7. doi: 10.1038/8394.
4
The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy.具有复制能力的HIV-1潜伏库的衰减与长期抗逆转录病毒治疗期间残余病毒复制的程度呈负相关。
Nat Med. 2000 Jan;6(1):82-5. doi: 10.1038/71577.
5
[Evaluation for two-year highly active antiretroviral therapy in Chinese HIV-1 infection patients].[中国HIV-1感染患者两年高效抗逆转录病毒治疗的评估]
Zhonghua Yi Xue Za Zhi. 2007 Nov 13;87(42):2973-6.
6
Strategies to decrease viral load rebound, and prevent loss of CD4 and onset of resistance during structured treatment interruptions.在结构化治疗中断期间降低病毒载量反弹、防止CD4细胞丢失和耐药性出现的策略。
Antivir Ther. 2004 Feb;9(1):123-32.
7
Detection and quantification of proviral HIV-1 184 M/V in circulating CD4(+) T cells of patients on HAART with a viremia less than 1,000 copies/ml.在接受高效抗逆转录病毒治疗(HAART)且病毒血症低于1000拷贝/毫升的患者循环CD4(+) T细胞中检测和定量原病毒HIV-1 184 M/V 。
J Clin Virol. 2005 Dec;34(4):257-67. doi: 10.1016/j.jcv.2005.02.015. Epub 2005 Apr 18.
8
Effect of prolonged discontinuation of successful antiretroviral therapy on CD4+ T cell decline in human immunodeficiency virus-infected patients: implications for intermittent therapeutic strategies.成功的抗逆转录病毒疗法长期中断对人类免疫缺陷病毒感染患者CD4 + T细胞减少的影响:对间歇性治疗策略的启示。
J Infect Dis. 2002 Sep 15;186(6):851-4. doi: 10.1086/342603. Epub 2002 Aug 28.
9
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.血浆病毒载量≤20拷贝/毫升的HIV-1感染患者的残余病毒血症与可溶性免疫激活标志物的血液水平升高有关。
Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x.
10
CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.1型人类免疫缺陷病毒(HIV-1)感染患者的CD4 + T细胞计数恢复与抗逆转录病毒治疗的类别无关。
Clin Infect Dis. 2008 Oct 15;47(8):1093-101. doi: 10.1086/592113.